Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Patsch

Showing results (1-10 of 168) with videos related to

Pageof 17
Sort By:
European Journal of Clinical Investigation|February 1, 1975
Lipoprotein of the density 1.006-1.020 in the plasma of patients with type III hyperlipoproteinaemia in the postabsorptive stateJ R Patsch
Der Internist|May 1, 1989
[Lipid-lowering drugs in preventing atherosclerosis]J R Patsch
Bailliere'S Clinical Endocrinology and Metabolism|August 1, 1987
Postprandial lipaemiaJ R Patsch
Acta Medica Austriaca|June 8, 2002
[Attitude to and marketing of cerivastatin]J R Patsch
Atherosclerosis|October 1, 1994
Triglyceride-rich lipoproteins and atherosclerosisJ R Patsch
Wiener Klinische Wochenschrift|April 12, 1985
[Structure and metabolism of high-density lipoproteins]J R Patsch
Wiener Medizinische Wochenschrift. Supplement|January 1, 1989
[Pathophysiology of lipid transport in plasma]J R Patsch
Current Problems in Dermatology|January 1, 1989
Immunodeficiency due to hormonal and metabolic disturbancesJ R Patsch
Acta Medica Austriaca. Supplement|January 1, 1977
[Structure and function of plasma lipoproteins]J R Patsch
Comprehensive Therapy|February 1, 1984
Exercise, high density lipoproteins, and fat toleranceJ R Patsch, W Patsch
Pageof 17

Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
European Journal of Clinical Investigation|February 1, 1975
Lipoprotein of the density 1.006-1.020 in the plasma of patients with type III hyperlipoproteinaemia in the postabsorptive stateJ R Patsch
Der Internist|May 1, 1989
[Lipid-lowering drugs in preventing atherosclerosis]J R Patsch
Bailliere'S Clinical Endocrinology and Metabolism|August 1, 1987
Postprandial lipaemiaJ R Patsch
Acta Medica Austriaca|June 8, 2002
[Attitude to and marketing of cerivastatin]J R Patsch
Atherosclerosis|October 1, 1994
Triglyceride-rich lipoproteins and atherosclerosisJ R Patsch
Wiener Klinische Wochenschrift|April 12, 1985
[Structure and metabolism of high-density lipoproteins]J R Patsch
Wiener Medizinische Wochenschrift. Supplement|January 1, 1989
[Pathophysiology of lipid transport in plasma]J R Patsch
Current Problems in Dermatology|January 1, 1989
Immunodeficiency due to hormonal and metabolic disturbancesJ R Patsch
Acta Medica Austriaca. Supplement|January 1, 1977
[Structure and function of plasma lipoproteins]J R Patsch
Comprehensive Therapy|February 1, 1984
Exercise, high density lipoproteins, and fat toleranceJ R Patsch, W Patsch
Pageof 17